Isocitrate dehydrogenase (IDH) is a key enzyme involved in the conversion of isocitrate to ?-ketoglutarate (?-KG) in the tricarboxylic acid (TCA) cycle. IDH inhibitor monotherapy for R/R AML is efficacious and safe; however, there are problems, such as primary or acquired resistance.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Isocitrate Dehydrogenase Inhibitors industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
IDH1 Mutant Medullary Malignant Tumor
IDH2 Mutant Medullary Malignant Tumor
Others
Market Segment by Product Application
DH Inhibitor
FLT3 Inhibitor
Hedgehog Pathway Inhibitor
Others
Finally, the report provides detailed profile and data information analysis of leading company.
AGIOS
Philogen S.p.A.
Beigene
Aslan Pharmaceuticals
Daiichi Sankyo
Bayer
Tragara/Adastra
Celgene
Bristol-Myers Squibb
Tesaro
Tocagen
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Isocitrate Dehydrogenase Inhibitors consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Isocitrate Dehydrogenase Inhibitors market by identifying its various subsegments.
3.Focuses on the key global Isocitrate Dehydrogenase Inhibitors manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Isocitrate Dehydrogenase Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Isocitrate Dehydrogenase Inhibitors submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Isocitrate Dehydrogenase Inhibitors Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Isocitrate Dehydrogenase Inhibitors Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Isocitrate Dehydrogenase Inhibitors Segment by Type
2.1.1 IDH1 Mutant Medullary Malignant Tumor
2.1.2 IDH2 Mutant Medullary Malignant Tumor
2.1.3 Others
2.2 Market Analysis by Application
2.2.1 DH Inhibitor
2.2.2 FLT3 Inhibitor
2.2.3 Hedgehog Pathway Inhibitor
2.2.4 Others
2.3 Global Isocitrate Dehydrogenase Inhibitors Market Comparison by Regions (2017-2027)
2.3.1 Global Isocitrate Dehydrogenase Inhibitors Market Size (2017-2027)
2.3.2 North America Isocitrate Dehydrogenase Inhibitors Status and Prospect (2017-2027)
2.3.3 Europe Isocitrate Dehydrogenase Inhibitors Status and Prospect (2017-2027)
2.3.4 Asia-pacific Isocitrate Dehydrogenase Inhibitors Status and Prospect (2017-2027)
2.3.5 South America Isocitrate Dehydrogenase Inhibitors Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Isocitrate Dehydrogenase Inhibitors Industry Impact
2.5.1 Isocitrate Dehydrogenase Inhibitors Business Impact Assessment - Covid-19
2.5.2 Market Trends and Isocitrate Dehydrogenase Inhibitors Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Isocitrate Dehydrogenase Inhibitors Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Isocitrate Dehydrogenase Inhibitors Manufacturer Market Share
3.5 Top 10 Isocitrate Dehydrogenase Inhibitors Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Isocitrate Dehydrogenase Inhibitors Market
3.7 Key Manufacturers Isocitrate Dehydrogenase Inhibitors Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Isocitrate Dehydrogenase Inhibitors Industry Key Manufacturers
4.1 AGIOS
4.1.1 Company Details
4.1.2 AGIOS Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AGIOS News
4.2 Philogen S.p.A.
4.2.1 Company Details
4.2.2 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.2.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Philogen S.p.A. News
4.3 Beigene
4.3.1 Company Details
4.3.2 Beigene Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.3.3 Beigene Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Beigene News
4.4 Aslan Pharmaceuticals
4.4.1 Company Details
4.4.2 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.4.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Aslan Pharmaceuticals News
4.5 Daiichi Sankyo
4.5.1 Company Details
4.5.2 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.5.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Daiichi Sankyo News
4.6 Bayer
4.6.1 Company Details
4.6.2 Bayer Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.6.3 Bayer Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Bayer News
4.7 Tragara/Adastra
4.7.1 Company Details
4.7.2 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.7.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Tragara/Adastra News
4.8 Celgene
4.8.1 Company Details
4.8.2 Celgene Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.8.3 Celgene Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Celgene News
4.9 Bristol-Myers Squibb
4.9.1 Company Details
4.9.2 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.9.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Bristol-Myers Squibb News
4.10 Tesaro
4.10.1 Company Details
4.10.2 Tesaro Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.10.3 Tesaro Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Tesaro News
4.11 Tocagen
4.11.1 Company Details
4.11.2 Tocagen Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification
4.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Tocagen News
5 Global Isocitrate Dehydrogenase Inhibitors Sales Categorized by Regions
5.1 Global Isocitrate Dehydrogenase Inhibitors Revenue, Sales and Market Share by Regions
5.1.1 Global Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Regions (2017-2022)
5.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Regions (2017-2022)
5.2 North America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
5.3 Europe Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
5.5 South America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
6 North America Isocitrate Dehydrogenase Inhibitors Market Size Categorized by Countries
6.1 North America Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Countries
6.1.1 North America Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
6.1.2 North America Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
6.1.3 United States Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
6.1.4 Canada Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
6.1.5 Mexico Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
6.2 North America Isocitrate Dehydrogenase Inhibitors Revenue (Value) by Manufacturers
6.3 North America Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Type (2017-2022)
6.4 North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2017-2022)
7 Europe Isocitrate Dehydrogenase Inhibitors Market Size Categorized by Countries
7.1 Europe Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Countries
7.1.1 Europe Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
7.1.3 Germany Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
7.1.4 UK Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
7.1.5 France Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
7.1.6 Russia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
7.1.7 Italy Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
7.1.8 Spain Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
7.2 Europe Isocitrate Dehydrogenase Inhibitors Revenue (Value) by Manufacturers
7.3 Europe Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Type (2017-2022)
7.4 Europe Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2017-2022)
8 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size Categorized by Countries
8.1 Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
8.1.3 China Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
8.1.4 South Korea Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
8.1.5 Japan Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
8.1.6 Australia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
8.1.7 India Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue (Value) by Manufacturers
8.3 Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2017-2022)
9 South America Isocitrate Dehydrogenase Inhibitors Market Size Categorized by Countries
9.1 South America Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Countries
9.1.1 South America Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
9.1.2 South America Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
9.1.3 Brazil Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
9.2 South America Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Type (2017-2022)
9.3 South America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2017-2022)
10 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Market Size Categorized by Countries
10.1 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
10.1.3 GCC Countries Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
10.1.4 Turkey Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
10.1.5 Egypt Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
10.1.6 South America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Type
10.3 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2017-2022)
11 Global Isocitrate Dehydrogenase Inhibitors Market Segment by Type
11.1 Global Isocitrate Dehydrogenase Inhibitors Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Isocitrate Dehydrogenase Inhibitors Sales and Market Share by Type (2017-2022)
11.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Type (2017-2022)
11.2 IDH1 Mutant Medullary Malignant Tumor Sales Growth Rate and Price
11.2.1 Global IDH1 Mutant Medullary Malignant Tumor Sales Growth Rate (2017-2022)
11.2.2 Global IDH1 Mutant Medullary Malignant Tumor Price (2017-2022)
11.3 IDH2 Mutant Medullary Malignant Tumor Sales Growth Rate and Price
11.3.1 Global IDH2 Mutant Medullary Malignant Tumor Sales Growth Rate (2017-2022)
11.3.2 Global IDH2 Mutant Medullary Malignant Tumor Price (2017-2022)
11.4 Others Sales Growth Rate and Price
11.4.1 Global Others Sales Growth Rate (2017-2022)
11.4.2 Global Others Price (2017-2022)
12 Global Isocitrate Dehydrogenase Inhibitors Market Segment by Application
12.1 Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2017-2022)
12.2 DH Inhibitor Sales Growth Rate (2017-2022)
12.3 FLT3 Inhibitor Sales Growth Rate (2017-2022)
12.4 Hedgehog Pathway Inhibitor Sales Growth Rate (2017-2022)
12.5 Others Sales Growth Rate (2017-2022)
13 Global Isocitrate Dehydrogenase Inhibitors Market Forecast
13.1 Global Isocitrate Dehydrogenase Inhibitors Revenue, Sales and Growth Rate (2022-2027)
13.2 Isocitrate Dehydrogenase Inhibitors Market Forecast by Regions (2022-2027)
13.2.1 North America Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
13.2.2 Europe Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
13.2.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
13.2.4 South America Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
13.2.5 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
13.3 Isocitrate Dehydrogenase Inhibitors Market Forecast by Type (2022-2027)
13.3.1 Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Type (2022-2027)
13.3.2 Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Type (2022-2027)
13.4 Isocitrate Dehydrogenase Inhibitors Market Forecast by Application (2022-2027)
13.4.1 Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Application (2022-2027)
13.4.2 Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Isocitrate Dehydrogenase Inhibitors Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Isocitrate Dehydrogenase Inhibitors Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Isocitrate Dehydrogenase Inhibitors
Figure Market Concentration Ratio and Market Maturity Analysis of Isocitrate Dehydrogenase Inhibitors
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Isocitrate Dehydrogenase Inhibitors Market Size by Type
Figure Global Market Share of Isocitrate Dehydrogenase Inhibitors by Type in 2021
Figure IDH1 Mutant Medullary Malignant Tumor Picture
Figure IDH2 Mutant Medullary Malignant Tumor Picture
Figure Others Picture
Table Global Isocitrate Dehydrogenase Inhibitors Market Size (Volume) by Application
Figure DH Inhibitor Picture
Figure FLT3 Inhibitor Picture
Figure Hedgehog Pathway Inhibitor Picture
Figure Others Picture
Table Global Isocitrate Dehydrogenase Inhibitors Comparison by Regions (M USD) 2017-2027
Figure Global Isocitrate Dehydrogenase Inhibitors Market Size (Million US$) (2017-2027)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Isocitrate Dehydrogenase Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Isocitrate Dehydrogenase Inhibitors Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Manufacturer (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Manufacturer in 2021
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Manufacturer (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturer in 2021
Table Global Isocitrate Dehydrogenase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Isocitrate Dehydrogenase Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Isocitrate Dehydrogenase Inhibitors Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Isocitrate Dehydrogenase Inhibitors Market
Table Key Manufacturers Isocitrate Dehydrogenase Inhibitors Product Type
Table Mergers & Acquisitions Planning
Table AGIOS Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of AGIOS
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AGIOS 2017-2022
Table AGIOS Main Business
Table AGIOS Recent Development
Table Philogen S.p.A. Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Philogen S.p.A.
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Philogen S.p.A. 2017-2022
Table Philogen S.p.A. Main Business
Table Philogen S.p.A. Recent Development
Table Beigene Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Beigene
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Beigene 2017-2022
Table Beigene Main Business
Table Beigene Recent Development
Table Aslan Pharmaceuticals Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Aslan Pharmaceuticals
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aslan Pharmaceuticals 2017-2022
Table Aslan Pharmaceuticals Main Business
Table Aslan Pharmaceuticals Recent Development
Table Daiichi Sankyo Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Daiichi Sankyo
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2017-2022
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Table Bayer Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Bayer
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Tragara/Adastra Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Tragara/Adastra
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Tragara/Adastra 2017-2022
Table Tragara/Adastra Main Business
Table Tragara/Adastra Recent Development
Table Celgene Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Celgene
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celgene 2017-2022
Table Celgene Main Business
Table Celgene Recent Development
Table Bristol-Myers Squibb Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Tesaro Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Tesaro
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Tesaro 2017-2022
Table Tesaro Main Business
Table Tesaro Recent Development
Table Tocagen Company Profile
Table Isocitrate Dehydrogenase Inhibitors Product Introduction, Application and Specification of Tocagen
Table Isocitrate Dehydrogenase Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Tocagen 2017-2022
Table Tocagen Main Business
Table Tocagen Recent Development
Figure Global Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2017-2022)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Regions (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Regions in 2021
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Regions (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Regions in 2021
Figure North America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Europe Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure South America Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2017-2022)
Table North America Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
Table North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2017-2022)
Figure North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2021
Table North America Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
Table North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2017-2022)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2021
Figure United States Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Canada Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Mexico Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Table North America Isocitrate Dehydrogenase Inhibitors Revenue by Manufacturer (2021)
Figure North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturer in 2021
Table North America Isocitrate Dehydrogenase Inhibitors Sales by Type (2017-2022)
Table North America Isocitrate Dehydrogenase Inhibitors Sales Share by Type (2017-2022)
Table North America Isocitrate Dehydrogenase Inhibitors Sales by Application (2017-2022)
Table North America Isocitrate Dehydrogenase Inhibitors Sales Share by Application (2017-2022)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2017-2022)
Table Europe Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
Table Europe Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2017-2022)
Figure Europe Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2021
Table Europe Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
Table Europe Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2017-2022)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2021
Figure Germany Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure UK Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure France Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Russia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Italy Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Spain Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Table Europe Isocitrate Dehydrogenase Inhibitors Revenue by Manufacturer (2021)
Figure Europe Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturer in 2021
Table Europe Isocitrate Dehydrogenase Inhibitors Sales by Type (2017-2022)
Table Europe Isocitrate Dehydrogenase Inhibitors Sales Share by Type (2017-2022)
Table Europe Isocitrate Dehydrogenase Inhibitors Sales by Application (2017-2022)
Table Europe Isocitrate Dehydrogenase Inhibitors Sales Share by Application (2017-2022)
Figure Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2017-2022)
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2021
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2021
Figure China Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure South Korea Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Japan Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Australia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure India Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Southeast Asia Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue by Manufacturer (2021)
Figure Asia-pacific Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales by Type (2017-2022)
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales Share by Type (2017-2022)
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales by Application (2017-2022)
Table Asia-pacific Isocitrate Dehydrogenase Inhibitors Sales Share by Application (2017-2022)
Figure South America Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2017-2022)
Figure South America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2019
Table South America Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2017-2022)
Figure South America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2019
Figure Brazil Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Sales by Type (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Sales Share by Type (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Revenue by Type (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Revenue Share by Type (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Sales by Application (2017-2022)
Table South America Isocitrate Dehydrogenase Inhibitors Sales Share by Application (2017-2022)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Market Share by Countries in 2019
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue by Countries (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Countries in 2019
Figure GCC Countries Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Turkey Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure Egypt Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Figure South Africa Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales by Type (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Share by Type (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue by Type (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue Share by Type (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales by Application (2017-2022)
Table Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Share by Application (2017-2022)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Type (2017-2022)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Type (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Type in 2021
Table Global Isocitrate Dehydrogenase Inhibitors Revenue by Type (2017-2022)
Table Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type in 2019
Figure Global IDH1 Mutant Medullary Malignant Tumor Sales Growth Rate (2017-2022)
Figure Global IDH1 Mutant Medullary Malignant Tumor Price (2017-2022)
Figure Global IDH2 Mutant Medullary Malignant Tumor Sales Growth Rate (2017-2022)
Figure Global IDH2 Mutant Medullary Malignant Tumor Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Others Price (2017-2022)
Table Global Isocitrate Dehydrogenase Inhibitors Sales by Application (2017-2022)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application in 2021
Figure Global DH Inhibitor Sales Growth Rate (2017-2022)
Figure Global FLT3 Inhibitor Sales Growth Rate (2017-2022)
Figure Global Hedgehog Pathway Inhibitor Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Isocitrate Dehydrogenase Inhibitors Sales and Growth Rate (2022-2027)
Figure Global Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2022-2027)
Table Global Isocitrate Dehydrogenase Inhibitors Sales Forecast by Regions (2017-2022)
Table Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Regions (2017-2022)
Figure North America Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
Figure Europe Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
Figure Asia-Pacific Sales Isocitrate Dehydrogenase Inhibitors Market Forecast (2022-2027)
Figure South America Sales Isocitrate Dehydrogenas
AGIOS
Philogen S.p.A.
Beigene
Aslan Pharmaceuticals
Daiichi Sankyo
Bayer
Tragara/Adastra
Celgene
Bristol-Myers Squibb
Tesaro
Tocagen